Rinko Ghosh, based in San Francisco, CA, US, is currently a President and CEO at IHP Therapeutics, bringing experience from previous roles at Engine Biosciences, Omniox, Symic Bio and Nektar Therapeutics. Rinko Ghosh holds a MBA in Finance and Strategic Management @ University of Pennsylvania - The Wharton School. With a robust skill set that includes Pharmaceutical Industry, Technology Transfer, Biotechnology, Biopharmaceuticals, Drug Development and more, Rinko Ghosh contributes valuable insights to the industry. Rinko Ghosh has 6 emails and 1 mobile phone number on RocketReach.